APG-157 Reduces HPV Viral Load and Activates Anti-Tumor Immunity in Head & Neck Cancer: Presentation at AACR 2026
Subpopulation analysis shows first-of-its-kind findings in HNSCC, with reduced HPV viral load and a gigaxonin-linked mechanism suggesting lower metastatic risk. LOS ANGELES, CA AND BEDFORD, MA, UNITED STATES, April 9, 2026 /EINPresswire.com/ — Aveta …https://www.einpresswire.com/article/904749875/apg-157-reduces-hpv-viral-load-and-activates-anti-tumor-immunity-in-head-neck-cancer-presentation-at-aacr-2026
